New MRI test could spare pancreatic cancer patients from needless surgery
NCT ID NCT07252076
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether an MRI scan can detect tiny liver metastases that standard CT scans miss in people with pancreatic cancer. About 120 adults with newly diagnosed pancreatic cancer will get both a CT and an MRI before treatment. If MRI proves better at finding hidden cancer spread, it could help doctors choose the right treatment and avoid unnecessary operations.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PANCREATIC DUCTAL ADENOCARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
SC Chirurgia Generale
RECRUITINGAlessandria, Piedmont, 15121, Italy
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can pancreatic Cancer's inflammatory footprint be stopped?
- Blood and gut clues may flag pancreatic cancer risk early
- Can a new drug combo shrink Hard-to-Treat tumors?
- Can a pill outsmart Tumors' defenses?
- A sound wave that could expose hidden pancreatic cancer?
- Can a new immunotherapy combo shrink Hard-to-Treat tumors?